Bergman Clinics has acquired MohsA Huidcentrum to enhance its dermatological care offerings in the Netherlands, emphasizing a shared commitment to high-quality medical services.

Target Information

MohsA Huidcentrum is an independent treatment center specializing in the management of skin cancer and other dermatological conditions. The clinic is committed to advancing its expertise in diagnosing and treating various skin disorders, operating facilities in Eindhoven, Venray, and Bladel. MohsA Huidcentrum collaborates closely with several university hospitals in the region and employs a large team of specialists, including dermatologists, medical assistants, nurses, and skin therapists, all focused on providing pain-free surgical procedures and treatments.

In addition to its top-tier cancer care, MohsA offers general dermatological services, including eczema treatments, varicose vein treatments, and skin therapy. This comprehensive range of services positions MohsA as a leader in the dermatology field within the Netherlands.

Industry Overview

The healthcare industry in the Netherlands has experienced significant transformations in recent years, particularly in the area of planned medical care. With a growing emphasis on patient-centric services, healthcare providers are

View Source

Similar Deals

Medtronic Fortimedix Surgical

2025

Merger Laser Equipment Netherlands
Caring Group Arion Group

2025

Merger Medical Equipment, Supplies & Distribution (NEC) Netherlands
Woonzorg Flevoland Buitenhaeghe

2025

Merger Residential & Long-Term Care Netherlands
Xpert Clinics Parkwegkliniek Sommer

2025

Merger Hospitals, Clinics & Primary Care Services Netherlands
XOMA Royalty LAVA Therapeutics

2025

Merger Biopharmaceuticals Netherlands
DELA Aerdehof

2024

Merger Healthcare Facilities & Services (NEC) Netherlands

Bergman Clinics

invested in

MohsA Huidcentrum

in 2024

in a Merger deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert